Document is current
Any future updates will be listed below
-
Authors
Hermida-Ameijeiras, Alvaro
Blasco-Alonso, Javier
Carrillo-Linares, Juan Luis
González-Dieguez, María Luisa
Pastor-Rosado, José
Morales-Conejo, Montserrat
Bellusci, Marcello
Mercadal-Hally, Maria https://orcid.org/0000-0003-1687-6448
-
Funding
Funding for this research was provided by:
Alexion Pharma (Alexion Pharma)
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 5 June 2025
First Online: 2 July 2025
Declarations
:
: Not applicable.
: Not applicable.
: AHA received speaker fees from Alexion; JBA has nothing to declare; JLCL received fees from Alexion; MLGD received consultant and speaker fees from Alexion; JPR has received conference payments from Astra Zeneca-Alexion; grants for attendance at scientific meetings, as well as fees for scientific consultancy from Astra Zeneca-Alexion; MMC received fees from Alexion and speaker fees from Sanofi, Taketa, Chiesi, Amicus and Biomarin; MB has nothing to declare; MMH received speaker fees from Alexion.
